ReviewCurrent diabetes reviews2026
Hybrid Deep Learning Framework for Continuous Blood Glucose Monitoring and Gestational Diabetes Risk Prediction.
Review in Current diabetes reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gestational diabetes mellitus (GDM) affects almost 10%-12% of pregnancies worldwide, threatening maternal and fetal life. Continuous glucose monitoring (CGM) forms the backbone of managing GDM, and the current methodologies largely disregard physiological and behavioral factors, thereby greatly reducing accuracy and clinical interpretability.
methodsA hybrid deep learning framework was developed by fusing CGM with multi-sensing modality data, including heart rate, activity levels, sleep patterns, and dietary intake. For data preprocessing, Kalman filtering was applied for temporal alignment, adaptive normalization provided outlier handling and imputation, while the CNN-BiLSTM backbone with attention was harnessed for feature extraction. A Multi-Task Attention Fusion Network (MTAFN) was used to predict glucose values and classify GDM risk simultaneously, while SHAP and dynamic smoothing contributed to interpretability sets.
resultsThe framework was validated on an extended OhioT1DM dataset with adaptations for pregnancy. It reached a glucose prediction RMSE of 9.8 mg/dL and a GDM risk classification accuracy of 93%. Compared to competitive approaches, the present solution attained a 25% better accuracy on interpretability and an improvement in sensitivity and specificity of about 4-6% across various physiological conditions. DISCUSSION: The use of multi-sensing data increased prediction robustness by capturing complex physiological dependencies. The SHAP-based interpretability justified the predictions through a physiological lens. With an attention mechanism for feature weighting, it was possible to identify crucial variables like meal intake and nighttime variability in the workflow sets.
conclusionThe hybrid framework proposed here is reliable for clinically interpretable continuous glucose monitoring and GDM risk predictions. Its application with high reliability can lead to integrating it within clinical protocols for real-time maternal care sets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.